IVERIC bio, Inc.

UBS Group AG

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

10,431

Value ($000)

410

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	410	0.0%	10,431	6/30/2023
2023 Q1	5/12/2023	2,698	0.0%	110,882	3/31/2023
2022 Q4	2/8/2023	5,787	0.0%	270,277	12/31/2022
2022 Q3	11/10/2022	1,496	0.0%	83,405	9/30/2022
2022 Q2	8/10/2022	1,930	0.0%	200,594	6/30/2022
2022 Q1	5/16/2022	379	0.0%	22,534	3/31/2022
2021 Q4	2/14/2022	414	0.0%	24,760	12/31/2021
2021 Q3	11/15/2021	342	0.0%	21,067	9/30/2021
2021 Q2	8/13/2021	138	0.0%	21,917	6/30/2021
2021 Q1	5/12/2021	130	0.0%	21,039	3/31/2021
2020 Q4	2/11/2021	42	0.0%	6,058	12/31/2020
2020 Q3	11/12/2020	7	0.0%	1,290	9/30/2020
2020 Q2	7/31/2020	8	0.0%	1,483	6/30/2020
2020 Q1	5/1/2020	5	0.0%	1,483	3/31/2020
2019 Q4	2/14/2020	4	0.0%	483	12/31/2019